We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Reinforced Stent Treats Venous Outflow Obstruction

By HospiMedica International staff writers
Posted on 17 Dec 2014
Print article
Image: The VICI Venous Stent System (Photo courtesy of Veniti).
Image: The VICI Venous Stent System (Photo courtesy of Veniti).
A new venous stent system conforms to the unique anatomy and pathophysiology of the venous system, including crush resistance, vessel coverage, and flexibility.

The Vici Venous Stent System is intended for use in veins of the lower extremities and pelvis, including the iliac and common femoral veins, and in patients who exhibit symptomatic venous outflow obstruction. The system comprises two components: the stent implant itself and the disposable delivery system. The stent is a laser cut, self-expanding tube made of a nickel titanium alloy (nitinol) with closed-cell segments and proprietary bridges and braces, designed to provide strength and flexibility in the venous anatomy.

Since venous disease requires a high degree of crush resistance, the radial stiffness of the venous stent is maximized to resist compression and improve vessel patency. The delivery system is a coaxial, over-the-wire (OTW) design with an exterior shaft to protect and constrain the stent prior to deployment. It is compatible with a 9F sheath introducer, and can be delivered via either a jugular or femoral vein approach. The Vici Venous Stent System is a product of Veniti (St. Louis, MO, USA), and has received the European Community CE marking of approval.

“The Veniti Vici venous stent appears to have the radial strength and vein coverage to provide optimal results in patients with symptomatic outflow obstruction of the lower extremities,” said Stephen Black, MD, a consultant vascular surgeon at St. George’s Vascular Institute (London, United Kingdom), who implanted Veniti Vici stents in five patients with symptomatic venous outflow obstruction of the lower extremities. “Having a stent that was designed from its inception for use in veins makes this an important addition to my treatment options.”

Symptomatic venous outflow obstruction of the iliofemoral vein is a common complication of deep vein thrombosis (DVT) and May-Thurner syndrome (MTS), which is caused when the left iliac vein is compressed by the right iliac artery, which increases the risk of DVT in the left extremity. Until the advent of stents, patients did not have many options, and were treated with compression stockings, by elevating the leg, or with different pharmaceutical agents.

Related Links:

Veniti


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Glassware Washer
Tiva 10-1VL

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.